OptiScan Imaging Limited (OIL) is an ASX-listed company engaged in the development of endomicroscopic imaging technologies for medical, translational and pre-clinical applications.
OptiScan's technology enables real-time, in vivo imaging at the cellular level in human and animal tissue, and is used by leading research institutions and hospitals in North America, Europe, Asia and Australia.